[en] The pathogenesis of canine sino-nasal aspergillosis (SNA) and lymphoplasmacytic rhinitis (LPR) remains poorly understood. The innate immune system is implicated in the etiology of human chronic rhinosinusitis. Therefore, we hypothesized that dysfunction in innate immunity could be implicated in the pathogenesis of SNA and LPR.
Expression of messenger RNA (mRNA) encoding Toll-like receptors (TLRs) 1 to 10 and NOD-like receptors (NODs) 1 and 2 in nasal mucosal biopsies from SNA or LPR dogs was compared with mucosa from healthy controls. Gene expression was quantified using quantitative real-time reverse transcriptase polymerase chain reaction normalized against multiple housekeeper genes.
All TLR and NOD genes were quantified in all samples. SNA was associated with significantly increased expression of TLRs 1, 2, 3, 4, 6, 7, 8, 9 and 10; and NOD2, relative to controls. LPR was associated with significantly increased expression of TLRs 1, 2, 6, 7 and 8, relative to controls. There was significantly more expression of TLRs 1, 4, 6, 7, 8, 9, 10 and NOD2 in SNA dogs than in LPR dogs. The significance of these differences in the pathogenesis of these diseases is yet to be determined.
Disciplines :
Veterinary medicine & animal health
Author, co-author :
Mercier, Elise ; Université de Liège - ULiège > Département clinique des animaux de compagnie et des équidés > Pathologie médicale des petits animaux
Peters, Iain
Clercx, Cécile ; Université de Liège - ULiège > Département clinique des animaux de compagnie et des équidés > Pathologie médicale des petits animaux
Day, Michael
Peeters, Dominique ; Université de Liège - ULiège > Département clinique des animaux de compagnie et des équidés > Médecine interne des animaux de compagnie
Language :
English
Title :
Toll- and NOD-like receptor mRNA expression in canine sino-nasal aspergillosis and idiopathic lymphoplasmacytic rhinitis
Agrawal S., Agrawal A., Doughty B., Gerwitz A., Blenis J., Van Dyke T., Pulendran B. Cutting edge: different Toll-like receptor agonists instruct dendritic cells to induce distinct Th responses via differential modulation of extracellular signal-regulated kinase-mitogen-activated protein kinase and c-Fos. J. Immunol. 2003, 171:4984-4989.
Agrawal S., Kandimalla E.R. Synthetic agonists of Toll-like receptors 7, 8 and 9. Biochem. Soc. Trans. 2007, 35:1461-1467.
Allenspach K., House A., Smith K., McNeill F.M., Hendricks A., Elson-Riggins J., Riddle A., Steiner J.M., Werling D., Garden O.A., Catchpole B., Suchodolski J.S. Evaluation of mucosal bacteria and histopathology, clinical disease activity and expression of Toll-like receptors in German shepherd dogs with chronic enteropathies. Vet. Microbiol. 2010, 146:326-335.
Becker C.E., O'Neill L.A. Inflammasomes in inflammatory disorders: the role of TLRs and their interactions with NLRs. Semin. Immunopathol. 2007, 29:239-248.
Bell M.P., Svingen P.A., Rahman M.K., Xiong Y., Faubion W.A. FOXP3 regulates TLR10 expression in human T regulatory cells. J. Immunol. 2007, 179:1893-1900.
Bellocchio S., Montagnoli C., Bozza S., Gaziano R., Rossi G., Mambula S.S., Vecchi A., Mantovani A., Levitz S.M., Romani L. The contribution of the Toll-like/IL-1 receptor superfamily to innate and adaptive immunity to fungal pathogens in vivo. J. Immunol. 2004, 172:3059-3069.
Bogefors J., Rydberg C., Uddman R., Fransson M., Månsson A., Benson M., Adner M., Cardell L.O. Nod1 Nod2 and Nalp3 receptors, new potential targets in treatment of allergic rhinitis?. Allergy 2010, 65:1222-1226.
Camateros P., Tamaoka M., Hassan M., Marino R., Moisan J., Marion D., Guiot M.C., Martin J.G., Radzioch D. Chronic asthma-induced airway remodeling is prevented by Toll-like receptor-7/8 ligand S28463. Am. J. Respir. Crit. Care Med. 2007, 175:1241-1249.
Chai L.Y., Kullberg B.J., Vonk A.G., Warris A., Cambi A., Latge J.P., Joosten L.A., van der Meer J.W., Netea M.G. Modulation of Toll-like receptor 2 (TLR2) and TLR4 responses by Aspergillus fumigatus. Infect. Immun. 2009, 77:2184-2192.
Claeys S., Van Hoecke H., Holtappels G., Gevaert P., De Belder T., Verhasselt B., Van Cauwenberge P., Bachert C. Nasal polyps in patients with and without cystic fibrosis: a differentiation by innate markers and inflammatory mediators. Clin. Exp. Allergy 2005, 35:467-472.
Dillon S., Agrawal A., Van Dyke T., Landreth G., McCauley L., Koh A., Maliszewski C., Akira S., Pulendran B. A Toll-like receptor 2 ligand stimulates Th2 responses in vivo, via induction of extracellular signal-regulated kinase mitogen-activated protein kinase and c-Fos in dendritic cells. J. Immunol. 2004, 172:4733-4743.
Dong Z., Yang Z., Wang C. Expression of TLR2 and TLR4 messenger RNA in the epithelial cells of the nasal airway. Am. J. Rhinol. 2005, 19:236-239.
Franchi L., Park J.H., Shaw M.H., Marina-Garcia N., Chen G., Kim Y.G., Nunez G. Intracellular NOD-like receptors in innate immunity, infection and disease. Cell Microbiol. 2008, 10:1-8.
Fransson M., Adner M., Erjefalt J., Jansson L., Uddman R., Cardell L.O. Up-regulation of Toll-like receptors 2, 3 and 4 in allergic rhinitis. Respir. Res. 2005, 6:100.
Grammer L.C., Tancowny B., Truong-Tran Q., Lee J., Peters A., Harris K., Conley D., Kern R., Schleimer R. Analysis of the TLR2 signaling pathway in nasal epithelial cells from patients with chronic rhinosinusitis (CRS). J. Allergy Clin. Immunol. 2007, 119:S242.
Hayashi F., Smith K.D., Ozinsky A., Hawn T.R., Yi E.C., Goodlett D.R., Eng J.K., Akira S., Underhill D.M., Aderem A. The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5. Nature 2001, 410:1099-1103.
Hessel E.M., Chu M., Lizcano J.O., Chang B., Herman N., Kell S.A., Wills-Karp M., Coffman R.L. Immunostimulatory oligonucleotides block allergic airway inflammation by inhibiting Th2 cell activation and IgE-mediated cytokine induction. J. Exp. Med. 2005, 202:1563-1573.
Horak F. VTX-1463, a novel TLR8 agonist for the treatment of allergic rhinitis. Expert. Opin. Investig. Drugs 2011, 20:981-986.
Hussain I., Jain V.V., Kitagaki K., Businga T.R., O'Shaughnessy P., Kline J.N. Modulation of murine allergic rhinosinusitis by CpG oligodeoxynucleotides. Laryngoscope 2002, 112:1819-1826.
Iwasaki A., Medzhitov R. Toll-like receptor control of the adaptive immune responses. Nat. Immunol. 2004, 5:987-995.
Kathrani A., House A., Catchpole B., Murphy A., German A., Werling D., Allenspach K. Polymorphisms in the TLR4 and TLR5 gene are significantly associated with inflammatory bowel disease in German shepherd dogs. PLoS One 2010, 5:e15740.
Kathrani A., House A., Catchpole B., Murphy A., Werling D., Allenspach K. Breed-independent Toll-like receptor 5 polymorphisms show association with canine inflammatory bowel disease. Tissue Antigens 2011, 78:94-101.
Lane A.P., Truong-Tran Q.A., Myers A., Bickel C., Schleimer R.P. Serum amyloid A, properdin, complement 3, and Toll-like receptors are expressed locally in human sinonasal tissue. Am. J. Rhinol. 2006, 20:117-123.
Lane A.P., Truong-Tran Q.A., Schleimer R.P. Altered expression of genes associated with innate immunity and inflammation in recalcitrant rhinosinusitis with polyps. Am. J. Rhinol. 2006, 20:138-144.
Mambula S.S., Sau K., Henneke P., Golenbock D.T., Levitz S.M. Toll-like receptor (TLR) signaling in response to Aspergillus fumigatus. J. Biol. Chem. 2002, 277:39320-39326.
Månsson A., Bogefors J., Cervin A., Uddman R., Cardell L.O. NOD-like receptors in the human upper airways: a potential role in nasal polyposis. Allergy 2011, 66:621-628.
Marshall J.D., Abtahi S., Eiden J.J., Tuck S., Milley R., Haycock F., Reid M.J., Kagey-Sobotka A., Creticos P.S., Lichtenstein L.M., Van Nest G. Immunostimulatory sequence DNA linked to the Amb a 1 allergen promotes T(H)1 cytokine expression while downregulating T(H)2 cytokine expression in PBMCs from human patients with ragweed allergy. J. Allergy Clin. Immunol. 2001, 108:191-197.
Moisan J., Camateros P., Thuraisingam T., Marion D., Koohsari H., Martin P., Boghdady M.L., Ding A., Gaestel M., Guiot M.C., Martin J.G., Radzioch D. TLR7 ligand prevents allergen-induced airway hyperresponsiveness and eosinophilia in allergic asthma by a MYD88-dependent and MK2-independent pathway. Am. J. Physiol. Lung Cell. Mol. Physiol. 2006, 290:L987-L995.
Netea M.G., Ferwerda G., van der Graaf C.A., Van der Meer J.W., Kullberg B.J. Recognition of fungal pathogens by Toll-like receptors. Curr. Pharm. Des. 2006, 12:4195-4201.
Ooi E.H., Wormald P.J., Tan L.W. Innate immunity in the paranasal sinuses: a review of nasal host defenses. Am. J. Rhinol. 2008, 22:13-19.
Peeters D., Peters I.R., Clercx C., Day M.J. Quantification of mRNA encoding cytokines and chemokines in nasal biopsies from dogs with sino-nasal aspergillosis. Vet. Microbiol. 2006, 114:318-326.
Peeters D., Peters I.R., Helps C.R., Gabriel A., Day M.J., Clercx C. Distinct tissue cytokine and chemokine mRNA expression in canine sino-nasal aspergillosis and idiopathic lymphoplasmacytic rhinitis. Vet. Immunol. Immunopathol. 2007, 117:95-105.
Peters I.R., Helps C.R., Hall E.J., Day M.J. Real-time RT-PCR: considerations for efficient and sensitive assay design. J. Immunol. Methods 2004, 286:203-217.
Peters I.R., Peeters D., Helps C.R., Day M.J. Development and application of multiple internal reference (housekeeper) gene assays for accurate normalisation of canine gene expression studies. Vet. Immunol. Immunopathol. 2007, 117:55-66.
Ramanathan M., Lee W.K., Dubin M.G., Lin S., Spannhake E.W., Lane A.P. Sinonasal epithelial cell expression of Toll-like receptor 9 is decreased in chronic rhinosinusitis with polyps. Am. J. Rhinol. 2007, 21:110-116.
Re F., Strominger J.L. Toll-like receptor 2 (TLR2) and TLR4 differentially activate human dendritic cells. J. Biol. Chem. 2001, 276:37692-37699.
Redecke V., Hacker H., Datta S.K., Fermin A., Pitha P.M., Broide D.H., Raz E. Cutting edge: activation of Toll-like receptor 2 induces a Th2 immune response and promotes experimental asthma. J. Immunol. 2004, 172:2739-2743.
Rozen S., Skaletsky H. Primer3 on the WWW for General Users and for Biologist Programmers 2000, Humana Press, Totowa, NJ, pp. 365-386.
Sha Q., Truong-Tran A.Q., Plitt J.R., Beck L.A., Schleimer R.P. Activation of airway epithelial cells by Toll-like receptor agonists. Am. J. Respir. Cell Mol. Biol. 2004, 31:358-364.
Sharp N.J.H., Harvey C.E., Sullivan M. Canine nasal aspergillosis and penicilliosis. Comp. Cont. Educ. 1991, 13:41-47.
Shibolet O., Podolsky D.K. TLRs in the Gut IV. Negative regulation of Toll-like receptors and intestinal homeostasis: addition by subtraction. Am. J. Physiol. Gastrointest. Liver Physiol. 2007, 292:G1469-G1473.
Shin S.H., Ponikau J.U., Sherris D.A., Congdon D., Frigas E., Homburger H.A., Swanson M.C., Gleich G.J., Kita H. Chronic rhinosinusitis: an enhanced immune response to ubiquitous airborne fungi. J. Allergy Clin. Immunol. 2004, 114:1369-1375.
Stanislawowski M., Wierzbicki P.M., Golab A., Adrych K., Kartanowicz D., Wypych J., Godlewski J., Smoczynski M., Kmiec Z. Decreased Toll-like receptor-5 (TLR-5) expression in the mucosa of ulcerative colitis patients. J. Physiol. Pharmacol. 2009, 60(Suppl. 4):71-75.
Takeda K., Akira S. Toll-like receptors in innate immunity. Int. Immunol. 2005, 17:1-14.
Uematsu S., Fujimoto K., Jang M.H., Yang B.G., Jung Y.J., Nishiyama M., Sato S., Tsujimura T., Yamamoto M., Yokota Y., Kiyono H., Miyasaka M., Ishii K.J., Akira S. Regulation of humoral and cellular gut immunity by lamina propria dendritic cells expressing Toll-like receptor 5. Nat. Immunol. 2008, 9:769-776.
Vandermeer J., Sha Q., Lane A.P., Schleimer R.P. Innate immunity of the sinonasal cavity: expression of messenger RNA for complement cascade components and Toll-like receptors. Arch. Otolaryngol. Head Neck Surg. 2004, 130:1374-1380.
Vandesompele J., De Preter K., Pattyn F., Poppe B., Van Roy N., De Paepe A., Speleman F. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 2002, 3. RESEARCH0034.
Windsor R.C., Johnson L.R., Herrgesell E.J., De Cock H.E. Idiopathic lymphoplasmacytic rhinitis in dogs: 37 cases (1997-2002). J. Am. Vet. Med. Assoc. 2004, 224:1952-1957.
Zarember K.A., Godowski P.J. Tissue expression of human Toll-like receptors and differential regulation of Toll-like receptor mRNAs in leukocytes in response to microbes, their products, and cytokines. J. Immunol. 2002, 168:554-561.